Providers can advance healthcare by sharing de-identified LOCAL POPULATION imaging data with external researchers through a OneMedNet partnership. Pharmaceutical companies, Imaging AI developers, Device organizations, Clinical Research Organizations, and Core Labs overcome the long-standing challenges to find the volume and specificity of imaging RWD to fulfill their respective needs.Read About One iRWD Network Partner →
The FDA gains critical patient data diversity in clinical participant demographics and associated regulatory submissions. Without diversity in patient data, conclusions can lead to greater healthcare inequities or distortion through bias.
Ultimately, patient lives are improved by way of novel healthcare solutions that are safer, lower cost, more effective, and available sooner using high-quality imaging RWD. We all move one step closer to Precision Medicine!
OneMedNet has a growing network of providers (200+) that operate as a critical data source within the iRWD ecosystem. Partner advantages are numerous and recurring.
Optimize, accelerate, and diversify clinical studies using de-identified local imaging data.
Maximize the value of your significant data asset(s) and generate new revenue streams for project funding
Participate with near zero strain to internal systems, personnel, and processes.
COVID is a recent example of how quickly disease can develop and spread.
Diagnostics, Therapeutics, Devices and Artificial Intelligence need to evolve faster!
We hope you will consider joining the OneMedNet iRWD network.